FY2026 EPS Estimate for Sandoz Group Raised by Analyst

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) – Investment analysts at Erste Group Bank upped their FY2026 EPS estimates for Sandoz Group in a research report issued on Thursday, October 8th. Erste Group Bank analyst H. Engel now forecasts that the company will post earnings of $4.22 per share for the year, up from their prior estimate of $4.20. Erste Group Bank has a “Strong-Buy” rating on the stock. The consensus estimate for Sandoz Group’s current full-year earnings is $4.15 per share. Erste Group Bank also issued estimates for Sandoz Group’s FY2027 earnings at $4.56 EPS.

Sandoz Group Stock Up 2.7%

Shares of OTCMKTS:SDZNY opened at $88.20 on Tuesday. Sandoz Group has a one year low of $60.40 and a one year high of $94.15. The company has a 50-day simple moving average of $86.12 and a 200-day simple moving average of $84.14.

Sandoz Group Company Profile

Sandoz Group AG is a Switzerland-based pharmaceutical company focused on developing, manufacturing and marketing generic and biosimilar medicines. Its portfolio is designed to expand access to established treatments by offering alternatives to branded products after patent or regulatory exclusivity periods end.

The company supplies medicines across a range of therapeutic areas, including anti-infectives, ophthalmology, respiratory care, central nervous system treatments, dermatology, transplantation and immunology.